Meleady R - Search Results

1

Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project.

Meleady R, Ueland PM, Blom H, Whitehead AS, Refsum H, Daly LE, Vollset SE, Donohue C, Giesendorf B, Graham IM, Ulvik A, Zhang Y, Bjorke Monsen AL; EC Concerted Action Project: Homocysteine and Vascular Disease. Meleady R, et al. Am J Clin Nutr. 2003 Jan;77(1):63-70. doi: 10.1093/ajcn/77.1.63. Am J Clin Nutr. 2003. PMID: 12499324

2

Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation.

Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster D, Rozen R, Evans A, Graham IM, Whitehead AS. Gallagher PM, et al. Among authors: meleady r. Circulation. 1996 Nov 1;94(9):2154-8. doi: 10.1161/01.cir.94.9.2154. Circulation. 1996. PMID: 8901666

3

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Lúis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G, et al. Graham IM, et al. Among authors: meleady r. JAMA. 1997 Jun 11;277(22):1775-81. doi: 10.1001/jama.1997.03540460039030. JAMA. 1997. PMID: 9178790 Free article.

4

Plasma homocysteine as a cardiovascular risk factor: causal, consequential, or of no consequence?

Meleady R, Graham I. Meleady R, et al. Nutr Rev. 1999 Oct;57(10):299-305. doi: 10.1111/j.1753-4887.1999.tb06902.x. Nutr Rev. 1999. PMID: 10575905 Review.

5

Homocysteine as a risk factor for coronary artery disease.

Meleady RA, Graham IM. Meleady RA, et al. J Cardiovasc Risk. 1995 Jun;2(3):216-21. J Cardiovasc Risk. 1995. PMID: 7584796 Review.

6

Homocysteine and vascular disease: nature or nurture?

Meleady RA, Graham IM. Meleady RA, et al. J Cardiovasc Risk. 1998 Aug;5(4):233-7. J Cardiovasc Risk. 1998. PMID: 9919471 Review.

7

The benefit of lowering cholesterol: relative risk can be absolutely misleading!

Meleady R, Graham IM. Meleady R, et al. Ir J Med Sci. 1998 Apr-Jun;167(2):92-3. doi: 10.1007/BF02937945. Ir J Med Sci. 1998. PMID: 9638023 No abstract available.

8

Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke.

Harmon DL, Doyle RM, Meleady R, Doyle M, Shields DC, Barry R, Coakley D, Graham IM, Whitehead AS. Harmon DL, et al. Among authors: meleady r. Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):208-11. doi: 10.1161/01.atv.19.2.208. Arterioscler Thromb Vasc Biol. 1999. PMID: 9974399

9

Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.

Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GH. Verhoef P, et al. Among authors: meleady r. Eur Heart J. 1999 Sep;20(17):1234-44. doi: 10.1053/euhj.1999.1522. Eur Heart J. 1999. PMID: 10454975

10

Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease.

Cahill M, Karabatzaki M, Meleady R, Refsum H, Ueland P, Shields D, Mooney D, Graham I. Cahill M, et al. Among authors: meleady r. Br J Ophthalmol. 2000 Feb;84(2):154-7. doi: 10.1136/bjo.84.2.154. Br J Ophthalmol. 2000. PMID: 10655190 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters